Agility Health, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2017. For the quarter, the company reported net revenue of $18,848,190 compared to $16,093,046 a year ago. Loss from continuing operations before income taxes was $2,519,299 compared to $265,570 a year ago. Loss from continuing operations was $2,551,299 compared to $265,570 a year ago. Net loss was $2,901,384 compared to $363,742 a year ago. Loss per share basic and diluted was $0.03 compared to $0.01 a year ago. Comprehensive loss attributable to shareholders was $3,285,160 compared to $735,405 a year ago. Gross margin from operations for the second quarter was 23%, compared to 23% from a year ago. Earnings before interest, taxes, depreciation and amortization ("EBITDA") from continuing operations declined from earnings of $1.2 million to loss of $0.6 million from the second quarter of 2017 compared to the second quarter of 2016, primarily driven by a 68% increase in general and administrative costs resulting from transition of leadership and onetime financial advisory fees incurred in connection with cash management and pursuing strategies to reduce capital through debt and/or equity financing. For six months the company reported net revenue of $35,973,303 compared to $31,405,652 a year ago. Loss from continuing operations before income taxes was $3,601,581 compared to $630,513 a year ago. Loss from continuing operations was $3,665,581 compared to $630,513 a year ago. Net loss was $4,091,875 compared to $819,166 a year ago. Loss per share basic and diluted was $0.04 compared to $0.01 a year ago. Comprehensive loss attributable to shareholders was $4,839,298 compared to $1,397,769 a year ago.